[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:
4-May-2014

[ | E-mail ] Share Share

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research

Compound Formula Rehmannia alleviates dyskinesia in Parkinson's disease

Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life. Dr. Jiancheng He and co-workers from Shanghai University of Traditional Chinese Medicine in China established a model of Parkinson's disease dyskinesia in rats, and treated these animals with Compound Formula Rehmannia. They found that Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease by modulating neurotransmitter signaling in the corpus striatum. The relevant article has been published in the Neural Regeneration Research (Vol. 9, No. 4, 2014).

###

Article: " Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease," by Long Teng, Fang Hong, Chenguang Zhang, Jiancheng He, Haiying Wang (Shanghai University of Traditional Chinese Medicine, Shanghai, China) Teng L, Hong F, Zhang CG, He JC, Wang HY. Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease. Neural Regen Res. 2014;9(4):407-412.

Contact:

Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
http://www.nrronline.org/



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.